Investing.com — Modern Inch. (NASDAQ: ) shares rose 14% after remarks by Oracle (NYSE: ) Chairman Larry Ellison about the transformative potential of artificial intelligence (AI) in healthcare, particularly in early cancer detection and the development of personalized vaccines.
Ellison’s comments highlighted the potential for artificial intelligence to revolutionize healthcare by identifying cancer early with blood tests and enabling the rapid creation of individualized vaccines. The rise in Moderna shares also comes on the heels of President Donald Trump’s announcement of a $500 billion private sector investment in artificial intelligence infrastructure, which includes a joint venture known as Stargate involving OpenAI, SoftBank ( TYO: ) and Oracle. This initiative is intended to strengthen the role of artificial intelligence in healthcare by establishing data centers and creating jobs.
The Oracle chairman elaborated on how tiny tumor fragments circulating in the blood can be detected using AI-powered blood tests, leading to early cancer diagnosis. Consequently, artificial intelligence could play a key role in gene sequencing of cancerous tumors to formulate personalized vaccines. This mRNA vaccine could be produced robotically within 48 hours, offering a rapid and personalized response to cancer treatment.
While no specific analyst comments were provided, the market’s reaction to Ellison’s vision and significant private sector investment in AI infrastructure reflect strong investor interest in the intersection of healthcare and technology. The jump in Moderna’s share price is an indication of optimism about the company’s potential role in this AI-driven future of healthcare.
The healthcare implications of AI, especially in the context of Moderna’s expertise in mRNA technology, seem to be resonating with investors. As the industry moves toward more personalized and efficient healthcare solutions, companies like Moderna are at the forefront of these advancements, potentially reaping the benefits of increased investment and innovation in the field.
This article was generated with the help of AI and reviewed by an editor. See our T&C for more information.
